Nalaganje...

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience

Autologous hematopoietic stem cell transplantation (AHSCT) is a treatment option for relapsed and recurrent follicular lymphoma (R/R FL); however, its value in the rituximab era remains to be elucidated. To evaluate the safety and clinical outcome of AHSCT for relapsed FL, we present a retrospective...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Med Oncol
Main Authors: Helbig, Grzegorz, Krawczyk-Kulis, Malgorzata, Kopinska, Anna, Liwoch, Robert, Kyrcz-Krzemien, Slawomira
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221626/
https://ncbi.nlm.nih.gov/pubmed/25373321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-014-0310-3
Oznake: Označite
Brez oznak, prvi označite!